Luciferase Reporter Cell Line - C666-1

The C666-1 cell line is a well-established and widely used cell model in cancer research, specifically derived from nasopharyngeal carcinoma (NPC). This epithelial cell line was originally isolated from a recurrent nasopharyngeal tumor and is highly valuable due to its persistent expression of Epstein-Barr virus (EBV) antigens, a characteristic feature of NPC tumors. Unlike many other NPC cell lines, C666-1 cells maintain EBV episomes and express latent EBV genes such as LMP1, LMP2A, and EBNA1, making it a biologically relevant tool for studying EBV-driven tumorigenesis. These cells exhibit adherent growth characteristics and retain typical epithelial cell morphology, allowing researchers to study tumor cell behavior, metastasis, and treatment responses.

The luciferase reporter cell line – C666-1 utilizes the characteristics of the parental cell line and incorporates a luciferase gene construct, enabling quantitative real-time monitoring of specific biological activities. Its applications span multiple fields: in drug discovery, it facilitates high-throughput screening of compounds by measuring changes in luminescence intensity, indicating pathway activation or inhibition. For example, researchers use it to evaluate inhibitors targeting EBV-mediated oncogenic signaling or immunomodulatory agents. In mechanistic studies, this cell line helps decipher the transcriptional regulatory mechanisms of genes involved in metastasis, apoptosis, or inflammation by linking luciferase activity to promoter dynamics.